Kioga is excited to announce our latest milestone as we successfully raised $250,000 in funding—a testament to the strong support for our revolutionary approach to human health. At Kioga, we are redefining wellness through groundbreaking postbiotic technology that directly targets inflammation at its source. Born from over two decades of research at the University of Colorado Boulder, our innovative platform harnesses soil-derived microbes that humanity once relied upon, yet lost in modern environments. This funding enables us to further our pioneering work, accelerating development and research into our first-of-its-kind solutions targeting both mental and metabolic health via the gut-immune-brain axis.
Our award-winning approach is designed to offer scientifically validated solutions without the unwanted side effects typical of traditional treatments. With these funds, we plan to expand our research into nature-derived compounds that promote stress resilience and metabolic optimization, creating a new category of evidence-based ingredients designed to work in harmony with the body’s natural systems. Backed by the NIH and with multiple patents pending, our team—founded by the scientific leader behind Meati Foods and a group of esteemed psychoneuroimmunology researchers—continues to push the boundaries of what is possible in modern wellness.
Looking ahead to our anticipated product launch in 2026, this infusion of capital is instrumental in bringing nature’s most powerful tools to a broader market. We are grateful for the continued support from our investors and stakeholders as we work toward building a future where breakthrough science meets accessible wellness for everyone, empowering individuals to achieve lasting resilience, clarity, and well-being.
.png&w=3840&q=75)
